RecA Inhibitors Potentiate Antibiotic Activity and Block Evolution of Antibiotic Resistance

Area of Science:

• Microbiology
• Molecular Biology
• Drug Discovery

Background:

• Antibiotic resistance is a growing global health threat.
• Resistance develops through mutations and gene transfer, often activated by antibiotic therapy via SOS response pathways.
• The SOS response involves RecA activation, LexA inactivation, and induction of SOS genes.

Purpose of the Study:

• To identify and characterize inhibitors of the RecA protein.
• To evaluate the efficacy of these inhibitors in potentiating antibiotic activity and preventing resistance development.

Main Methods:

• Identification and characterization of phthalocyanine tetrasulfonic acid derivatives as RecA inhibitors.
• Testing the inhibitors' effect on antibiotic-induced SOS response in bacteria.
• Assessing the impact of inhibitors on antibiotic potentiation and resistance acquisition in Gram-negative and Gram-positive bacteria.

Main Results:

• Phthalocyanine tetrasulfonic acid derivatives were identified as RecA inhibitors.
• These inhibitors effectively block antibiotic-induced SOS response activation.
• Inhibitors potentiated bactericidal antibiotics and reduced the acquisition and transfer of resistance genes.

Conclusions:

• RecA inhibitors offer a promising strategy to enhance existing antibiotic therapies.
• Combining RecA inhibitors with bactericidal antibiotics can combat antibiotic resistance.
• This approach may extend the clinical utility and shelf life of antibiotics.